The UK's medicines regulator has announced new guidelines to increase confidence and safety in the use of homeopathic medicines.
The National Rules Scheme will encourage the registration of new medicines by manufacturers and in return labels will be allowed to include information on the treatment of minor conditions by the product, announced the Medicines and Healthcare products Regulatory Agency (MHRA).
Chilblains, coughs, stomach complaints and insomnia are all commonly treated by such medicines, which will now be able to include "clear and comprehensive" patient information leaflets in order to help consumers to use the medication safely and effectively.
"This is a significant step forward in the way homeopathic medicines are regulated," said Professor Kent Woods, chief executive of the MHRA.
"Products authorised under the National Rules Scheme will have to comply with recognised standards of quality, safety and patient information."
The new rules have been welcomed by the British Association of Homeopathic Manufacturers, which believes the move will increase market growth and consumer understanding.